Filing Details

Accession Number:
0000899243-19-024147
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-09-24 16:05:22
Reporting Period:
2019-09-20
Accepted Time:
2019-09-24 16:05:22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1552451 Myokardia Inc MYOK Pharmaceutical Preparations (2834) 455500552
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1654909 Jake Bauer C/O Myokardia, Inc.
333 Allerton Avenue
South San Francisco CA 94080
Chief Business Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-09-20 10,000 $9.08 76,068 No 4 M Direct
Common Stock Acquisiton 2019-09-20 9,700 $12.25 85,768 No 4 M Direct
Common Stock Disposition 2019-09-20 19,700 $60.09 66,068 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2019-09-20 10,000 $0.00 10,000 $9.08
Common Stock Stock Option (Right to Buy) Disposition 2019-09-20 9,700 $0.00 9,700 $12.25
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
18,748 2026-02-01 No 4 M Direct
40,150 2027-01-17 No 4 M Direct
Footnotes
  1. This transaction was effected pursuant to a Rule 10b5-1 trading plan that was previously adopted by the Reporting Person.
  2. Represents the weighted average sale price of the shares sold ranging from $60.00 to $60.27 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
  3. The shares subject to this option vest and become exercisable in 48 equal monthly installments from January 1, 2016, subject to the Reporting Person's continued service to the Issuer through each vesting date.
  4. The shares subject to this option vest and become exercisable in 48 equal monthly installments from January 1, 2017, subject to the Reporting Person's continued service to the Issuer through each vesting date.